Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Quoin Pharmaceuticals Ltd QNRX

Healthcare Biotechnology

Quoin Pharmaceuticals Ltd, former Cellect Biotechnology Ltd, is an Israel-based specialty pharmaceutical company, focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The Company’s first lead product is QRX003, a once daily, topical lotion comprised of a broad-spectrum serine protease inhibitor, formulated with the proprietary Invisicare technology... see more

Add To Watchlist

Recent & Breaking News (NDAQ:QNRX)

Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results

PR Newswire May 17, 2018

Former GE Healthcare Executive to Join Cellect as Chief Business Officer

PR Newswire May 10, 2018

Benzinga Pro's 5 Stocks To Watch Today

Benzinga.com April 9, 2018

Cellect Announces a Major Milestone for Enabling Stem Cells Production

PR Newswire April 9, 2018

Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

PR Newswire March 19, 2018

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

Canada NewsWire February 1, 2018

Cellect Biotechnology Announces $4 Million Registered Direct Offering

PR Newswire January 29, 2018

Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation

PR Newswire January 16, 2018

7 Stocks Moving In Tuesday's After-Hours Session

Benzinga.com January 9, 2018

Mid-Afternoon Market Update: Dow Rises Over 150 Points; L Brands Shares Plunge

Benzinga.com January 4, 2018

Mid-Day Market Update: Buckle Drops After December Sales Results; ChemoCentryx Shares Spike Higher

Benzinga.com January 4, 2018

Mid-Morning Market Update: Markets Open Higher; Walgreens Earnings Top Views

Benzinga.com January 4, 2018

Cellect Announces Breakthrough Clinical Results

PR Newswire January 4, 2018

Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2017 Financial Results

PR Newswire November 22, 2017

Cellect CEO, Dr. Shai Yarkoni Selected as Keynote Speaker at the 11th World Congress of Regenerative Medicine & Stem Cell in Singapore

PR Newswire November 10, 2017

Cellect Chosen Among Selected Global Leaders Presenting at Bio-Europe 2017 Conference Addressing over 3,800 Industry Specialists from Over 2,000 World Leading Companies

PR Newswire October 31, 2017

Mid-Afternoon Market Update: Acadia Healthcare Tumbles After Downbeat Results; MacroGenics Shares Surge

Benzinga.com October 25, 2017

Mid-Day Market Update: Dow Falls Over 100 Points; Chipotle Shares Drop On Earnings Miss

Benzinga.com October 25, 2017

Mid-Morning Market Update: Markets Mostly Lower; Coca-Cola Tops Q3 Estimates

Benzinga.com October 25, 2017

Cellect Announces a Major Breakthrough of its ApoGraft™ Technology: Reporting Today Positive Results from a 20 Patients Trial With Tel-Aviv Ichilov Medical Center

PR Newswire October 25, 2017